Study: NCT06340581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: BGF MDI HFA
Description: Participants will receive 4 oral inhalations of BGF MDI HFA as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose with AeroChamber Plus Flow-Vu spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: BGF MDI HFO
Description: Participants will receive 4 oral inhalations of BGF MDI HFO as a single dose without spacer with charcoal.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus Flow-Vu Spacer
Description: Participants will receive 4 inhalations of BGF MDI HFA (treatment A) and BGF MDI HFO (Treatment B) as a single dose with AeroChamber Plus Flow-Vu spacer.